Supernus at Citibank and RBC Global Healthcare Conferences in February

  Supernus at Citibank and RBC Global Healthcare Conferences in February

Business Wire

ROCKVILLE, Md. -- February 7, 2014

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN), a specialty pharmaceutical
company, today announced that the Company’s management will be hosting
investor meetings during Citi’s 2014 Global Healthcare Conference.

Date: Tuesday, February 25
Place: The Hilton New York Hotel

Investors interested in arranging a meeting during this conference should
contact their Citi representative.

Supernus also announced that management will provide a business update on the
Company at the 2014 RBC Capital Markets Global Healthcare Conference.

Date: Wednesday, February 26
Presentation Time: 9:00am ET
Place: The New York Palace, New York, NY

About Supernus Pharmaceuticals, Inc.

Supernus Pharmaceuticals, Inc. is a specialty pharmaceutical company focused
on developing and commercializing products for the treatment of central
nervous system, or CNS, diseases. The Company has two marketed products for
epilepsy, Oxtellar XR® (extended-release oxcarbazepine) and Trokendi XR™
(extended-release topiramate). The Company is also developing several product
candidates in psychiatry to address large market opportunities in ADHD,
including ADHD patients with impulsive aggression. These product candidates
include SPN-810 for impulsive aggression in ADHD and SPN-812 for ADHD.

Contact:

Supernus Pharmaceuticals, Inc.
Jack A. Khattar, President and CEO
Gregory S. Patrick, Vice President and CFO
301-838-2591
or
Investor Contact:
Cockrell Group
877-889-1972
investorrelations@thecockrellgroup.com
cockrellgroup.com
 
Press spacebar to pause and continue. Press esc to stop.